• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用促性腺激素预处理的闭经患者经鼻腔应用合成促性腺激素释放激素后的激素反应。

Hormonal responses to nasal application of synthetic gonadotropin-releasing hormone in amenorrheic patients pretreated with gonadotropins.

作者信息

Potashnik G, Homburg R, Eshkol A, Insler V, Lunenfeld B

出版信息

Int J Fertil. 1980;25(3):234-8.

PMID:6108934
Abstract

Synthetic gonadotropin-releasing hormone (GnRH) in the form of nasal drops was self-administered by five amenorrheic patients in an attempt to assess its therapeutic value in anovulatory infertility. After follicular maturation had been induced with human menopausal gonadotropins (HMG), a total daily dose of 7.5 mg of GnRH in the form of nasal drops was self-administered at 2-hour intervals for 6 hours on 3 consecutive days. In four patients, plasma luteinizing hormone (LH) levels were significantly elevated over a period of at least 8 hours. In three of these patients, in addition, there was a definite upward shift in the basal body temperature (BBT) curve, and uterine bleeding occurred 6 to 9 days after the first dose of GnRH. In the fourth patient, ovulation was induced as indicated by a biphasic BBT curve, a plasma progesterone level of 13 ng/ml, and a luteal phase of 15 days. In the remaining patient, there was a borderline LH response and no clinical response. It is concluded that GnRH, in the form of nasal drops, is effective in eliciting and maintaining elevated plasma LH levels in patients in whom follicular maturation has been induced with HMG. By obtaining ovulatory LH levels, such a regimen can lead to ovulation. In addition intranasal self-administration of GnRH is convenient and may provide an alternative route of administration for long-term therapy with this hormone.

摘要

五名闭经患者自行使用滴鼻剂形式的合成促性腺激素释放激素(GnRH),以评估其在无排卵性不孕症中的治疗价值。在用人类绝经期促性腺激素(HMG)诱导卵泡成熟后,连续3天每天以2小时间隔自行使用总量为7.5毫克的滴鼻剂形式的GnRH,共6小时。在四名患者中,血浆黄体生成素(LH)水平在至少8小时内显著升高。此外,在其中三名患者中,基础体温(BBT)曲线有明确的上升变化,且在首次使用GnRH后6至9天出现子宫出血。在第四名患者中,双相BBT曲线、血浆孕酮水平为13纳克/毫升以及黄体期为15天表明诱导了排卵。在其余一名患者中,LH反应处于临界水平且无临床反应。得出的结论是,滴鼻剂形式的GnRH可有效促使并维持用HMG诱导卵泡成熟患者的血浆LH水平升高。通过获得排卵时的LH水平,这样的方案可导致排卵。此外,GnRH鼻内自行给药方便,可为该激素的长期治疗提供另一种给药途径。

相似文献

1
Hormonal responses to nasal application of synthetic gonadotropin-releasing hormone in amenorrheic patients pretreated with gonadotropins.用促性腺激素预处理的闭经患者经鼻腔应用合成促性腺激素释放激素后的激素反应。
Int J Fertil. 1980;25(3):234-8.
2
Hormonal and clinical responses in amenorrhetic patients treated with gonadotropins and a nasal form of synthetic gonadotropin-releasing hormone.用促性腺激素和鼻腔形式的合成促性腺激素释放激素治疗闭经患者的激素和临床反应。
Fertil Steril. 1978 Feb;29(2):148-52. doi: 10.1016/s0015-0282(16)43091-8.
3
Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.使用促性腺激素释放激素激动剂D-Ser(TBU)6-EA10-LRH对女性和男性进行长期避孕治疗。
Int J Fertil. 1980;25(3):239-46.
4
Augmentation of gonadotropin-releasing hormone induced follicular growth with exogenous gonadotropins.外源性促性腺激素增强促性腺激素释放激素诱导的卵泡生长。
Fertil Steril. 1987 Dec;48(6):954-7.
5
Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
Fertil Steril. 1985 Dec;44(6):744-50. doi: 10.1016/s0015-0282(16)49031-x.
6
Luteinizing hormone-releasing hormone for induction of follicular maturation and ovulation in women with infertility and amenorrhea.促黄体生成素释放激素用于诱导不孕和闭经女性的卵泡成熟与排卵。
Fertil Steril. 1976 Jun;27(6):621-7. doi: 10.1016/s0015-0282(16)41890-x.
7
Ovulation induction with pulsatile gonadotropin-releasing hormone (GnRH) or gonadotropins in a case of hypothalamic amenorrhea and diabetes insipidus.在下丘脑性闭经合并尿崩症的病例中,采用脉冲式促性腺激素释放激素(GnRH)或促性腺激素进行促排卵治疗。
Gynecol Endocrinol. 2001 Dec;15(6):421-5.
8
[Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
Zhonghua Fu Chan Ke Za Zhi. 1997 Oct;32(10):589-92.
9
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.在多囊卵泡发育病例中,低剂量人绒毛膜促性腺激素用于GnRH激动剂触发排卵后黄体支持的安全性和有效性。
Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. doi: 10.1016/j.ejogrb.2005.11.013. Epub 2005 Dec 22.
10
Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.慢性促性腺激素释放激动剂给药后多囊卵巢疾病的口服避孕药治疗。持续卵巢抑制的预测因素。
J Reprod Med. 1996 Sep;41(9):645-52.